Fabino Enterprises Ltd
Incorporated in 2011, Fabino Enterprises manufactures, markets, trades, and does packing of pharmaceutical and other wellness focused consumer products[1]
- Market Cap ₹ 5.46 Cr.
- Current Price ₹ 26.0
- High / Low ₹ 39.0 / 22.8
- Stock P/E 91.0
- Book Value ₹ 20.0
- Dividend Yield 0.00 %
- ROCE 5.61 %
- ROE 1.44 %
- Face Value ₹ 10.0
Pros
- Company's working capital requirements have reduced from 212 days to 104 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 288 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 3.36 | 21.01 | 17.98 | |
| 3.33 | 20.89 | 17.87 | |
| Operating Profit | 0.03 | 0.12 | 0.11 |
| OPM % | 0.89% | 0.57% | 0.61% |
| 0.02 | 0.01 | 0.29 | |
| Interest | 0.01 | 0.04 | 0.13 |
| Depreciation | 0.03 | 0.04 | 0.08 |
| Profit before tax | 0.01 | 0.05 | 0.19 |
| Tax % | 0.00% | 20.00% | 68.42% |
| 0.01 | 0.04 | 0.06 | |
| EPS in Rs | 0.05 | 0.19 | 0.29 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 50% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 2% |
| 1 Year: | -9% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 1% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Equity Capital | 2.10 | 2.10 | 2.10 |
| Reserves | 2.01 | 2.04 | 2.10 |
| 0.41 | 1.27 | 1.79 | |
| 0.50 | 9.95 | 11.67 | |
| Total Liabilities | 5.02 | 15.36 | 17.66 |
| 0.15 | 0.34 | 0.55 | |
| CWIP | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 |
| 4.87 | 15.02 | 17.11 | |
| Total Assets | 5.02 | 15.36 | 17.66 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| -0.68 | -0.77 | 0.12 | |
| -0.01 | -0.28 | -0.42 | |
| 0.34 | 0.86 | 0.48 | |
| Net Cash Flow | -0.35 | -0.18 | 0.18 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Debtor Days | 274.84 | 219.07 | 287.66 |
| Inventory Days | 147.24 | 24.21 | 26.56 |
| Days Payable | 45.78 | 179.31 | 252.78 |
| Cash Conversion Cycle | 376.29 | 63.97 | 61.44 |
| Working Capital Days | 444.30 | 86.34 | 104.14 |
| ROCE % | 1.81% | 5.61% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
30 Aug - Newspaper clippings - Notice of 14th Annual General Meeting
- Intimation Of Book Closure For 14Th Annual General Meeting 29 Aug
- Reg. 34 (1) Annual Report. 29 Aug
- Notice Of 14Thannual General Meeting (AGM) To Be Held On Monday, September 22, 2025 29 Aug
-
Announcement under Regulation 30 (LODR)-Resignation of Director
28 Aug - Nitin Mehra (DIN:08142337) resigned as Additional Executive Director effective August 28, 2025, citing personal reasons.
Business Overview:[1][2]
a) FEL is an ISO 9001:2015 pharmaceutical company located near the Delhi NCR region. It offers a wide range of allopathic and herbal products.
b) Company markets pharmaceutical formulation for domestic market and sells through own distribution network and sales force under
their own brand name
c) It gets Ayurvedic formulations manufactured through Loan Licensing facilities, Packing, Labelling etc.
d) Company exports wellness and FMCG products like Coffee, Malt powder, Protein powder, Hair shampoo which it also markets